Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. UMB Financial Corporation
10.7% sales growth and 7.26% return on equity
UMB Financial Corporation operates as the bank holding company for the UMB Bank that provides various banking and other financial services.
UMB Financial Corporation's sales growth this year is anticipated to be 10.3% and a negative 3.2% for next year.
Year-on-year quarterly revenue growth grew by 6.4%, now sitting on 1.02B for the twelve trailing months.
UMB Financial Corporation's sales growth for the next quarter is 10.7%. The company's growth estimates for the ongoing quarter and the next is 69.6% and 1957.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.26%.
Volatility
UMB Financial Corporation's last day, last week, and last month's average volatility was 1.43%, 1.97%, and 0.55%, respectively.
UMB Financial Corporation's last day, last week, and last month's high and low average amplitude percentage was 1.27%, 3.63%, and 2.81%, respectively.
UMB Financial Corporation's Stock Yearly Top and Bottom Value
UMB Financial Corporation's stock is valued at $76.45 at 16:22 EST, under its 52-week high of $76.86 and way above its 52-week low of $39.47.
UMB Financial Corporation's Moving Average
UMB Financial Corporation's worth is higher than its 50-day moving average of $69.82 and way higher than its 200-day moving average of $57.83.2. Quidel Corporation
424% sales growth and 53.6% return on equity
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, cardiology, thyroid, women's and general health, eye health, gastrointestinal diseases, and toxicology worldwide.
Quidel Corporation's sales growth this year is expected to be 211.2% and 91.9% for next year.
Year-on-year quarterly revenue growth grew by 276.4%, now sitting on 1B for the twelve trailing months.
Quidel Corporation's sales growth for the next quarter is 424%. The company's growth estimates for the present quarter and the next is 915% and 911.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 53.6%.
Volatility
Quidel Corporation's last day, last week, and last month's average volatility was a positive 0.05%, a positive 0.32%, and a negative 0.21%, respectively.
Quidel Corporation's last day, last week, and last month's high and low average amplitude percentage was 7.66%, 6.41%, and 6.69%, respectively.
Quidel Corporation's Stock Yearly Top and Bottom Value
Quidel Corporation's stock is valued at $204.49 at 16:22 EST, way below its 52-week high of $306.72 and way above its 52-week low of $71.90.
Quidel Corporation's Moving Average
Quidel Corporation's worth is above its 50-day moving average of $195.57 and under its 200-day moving average of $221.06.3. BioLife Solutions, Inc.
28.2% sales growth and 5.9% return on equity
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools for the cell and gene therapy industry in North America, Europe, the Middle East, Africa, and internationally.
BioLife Solutions, Inc.'s sales growth this year is anticipated to be 71.2% and 48.2% for next year.
Year-on-year quarterly revenue growth grew by 70.8%, now sitting on 41.66M for the twelve trailing months.
BioLife Solutions, Inc.'s sales growth for the next quarter is 28.2%. The company's growth estimates for the current quarter and the next is a negative 200% and negative -100%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.9%.
Volatility
BioLife Solutions, Inc.'s last day, last week, and last month's average volatility was a negative 0.42%, a positive 0.45%, and a positive 0.44%, respectively.
BioLife Solutions, Inc.'s last day, last week, and last month's high and low average amplitude percentage was 7.30%, 7.46%, and 6.25%, respectively.
BioLife Solutions, Inc.'s Stock Yearly Top and Bottom Value
BioLife Solutions, Inc.'s stock is valued at $40.80 at 16:22 EST, way below its 52-week high of $47.22 and way above its 52-week low of $7.37.
BioLife Solutions, Inc.'s Moving Average
BioLife Solutions, Inc.'s value is above its 50-day moving average of $39.80 and way above its 200-day moving average of $27.91.4. Louisiana
16.5% sales growth and 15.81% return on equity
Louisiana-Pacific Corporation, together with its subsidiaries, manufactures building products primarily for use in new home construction, repair and remodeling, and outdoor structure markets.
Louisiana's sales growth this year is anticipated to be 16% and 2.4% for next year.
Year-on-year quarterly revenue growth grew by 31.8%, now sitting on 2.46B for the twelve trailing months.
Louisiana's sales growth for the next quarter is 16.5%. The company's growth estimates for the present quarter and the next is 3140% and 244.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.81%.
Volatility
Louisiana's last day, last week, and last month's average volatility was a negative 5.05%, a positive 0.68%, and a positive 0.11%, respectively.
Louisiana's last day, last week, and last month's high and low average amplitude percentage was 6.48%, 4.50%, and 3.56%, respectively.
Louisiana's Stock Yearly Top and Bottom Value
Louisiana's stock is valued at $38.43 at 16:22 EST, under its 52-week high of $40.76 and way higher than its 52-week low of $12.97.
Louisiana's Moving Average
Louisiana's worth is higher than its 50-day moving average of $37.12 and way above its 200-day moving average of $31.91.Previous days news about Louisiana
According to Bloomberg Quint on Wednesday, 13 January, "Its Sabine Pass facility in Louisiana agreed last month to sell up to 30 spot cargoes during 2021."
According to Business Insider on Wednesday, 13 January, "And Eric Burns, an assistant professor of physics and astronomy at Louisiana State University in Baton Rouge, led a paper studying additional suspects that will appear in The Astrophysical Journal Letters."
According to Business Insider on Thursday, 14 January, "Wood earned his J.D./D.C.L. in 2013 from the Louisiana State University Paul M. Hebert Law Center. "
According to Business Insider on Friday, 15 January, "The refining assets consist of refineries operated in Tyler and Big Spring, Texas, El Dorado, Arkansas and Krotz Springs, Louisiana with a combined nameplate crude throughput capacity of 302,000 barrels per day."
According to Bloomberg Quint on Friday, 15 January, "Restaurant owners in New Orleans last month asked a Louisiana judge to order some Lloyd's of London insurers to cover losses from the outbreak, the first of a growing number of U.S. business-interruption claims to go to trial. "
According to Business Insider on Friday, 15 January, "The Gates family's biggest holdings are in Louisiana (69,071 acres), Arkansas (47,927 acres) and Nebraska (20,588 acres)."
According to Business Insider on Friday, 15 January, "A leader in the industry, IMTT has expanded from two Louisiana terminals to 19 terminals with approximately 50-million barrels of capacity across North America. "